Navigating GLP-1s and the Battle to Address Obesity and Cardiometabolic Disease -- Attendee Pre-Program Survey

Question Title

1. What are your biggest concerns about the use of GLP-1s for your workforce? Please Rank order the following statements

Question Title

2. Please indicate your level of agreement with each statement.

	Strongly Agree	Agree	Somewhat Agree	Disagree	Strongly Disagree
Weight loss is a challenge that each person needs to address/pay for themselves	Weight loss is a challenge that each person needs to address/pay for themselves Strongly Agree	Weight loss is a challenge that each person needs to address/pay for themselves Agree	Weight loss is a challenge that each person needs to address/pay for themselves Somewhat Agree	Weight loss is a challenge that each person needs to address/pay for themselves Disagree	Weight loss is a challenge that each person needs to address/pay for themselves Strongly Disagree
People who are obese should have access to whatever medical/behavioral science can offer	People who are obese should have access to whatever medical/behavioral science can offer Strongly Agree	People who are obese should have access to whatever medical/behavioral science can offer Agree	People who are obese should have access to whatever medical/behavioral science can offer Somewhat Agree	People who are obese should have access to whatever medical/behavioral science can offer Disagree	People who are obese should have access to whatever medical/behavioral science can offer Strongly Disagree
Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s.	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Strongly Agree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Agree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Somewhat Agree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Disagree	Only people who are morbidly obese should have access to expensive medical care/prescription drugs like GLP-1s. Strongly Disagree
GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Strongly Agree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Agree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Somewhat Agree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Disagree	GLP-1s are just one of several tools for addressing obesity and cardiometabolic risk Strongly Disagree

Question Title

3. What are your questions related to addressing obesity?

Question Title

4. Please share your experiences and/or questions about the efficacy of GLP-1s.

Question Title

5. Please share your experiences and/or questions about the cost of GLP-1s.

Question Title

6. Please share which solutions you are using to gate or support GLP-1s as part of your plans for addressing obesity/cardiometabolic risk.